scholarly article | Q13442814 |
meta-analysis | Q815382 |
P50 | author | Chunyi Wen | Q61093634 |
Li-Min Rong | Q88829616 | ||
P2093 | author name string | Yang Yang | |
Zhong-Yu Liu | |||
P2860 | cites work | European guidance for the diagnosis and management of osteoporosis in postmenopausal women | Q24612411 |
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860749 | ||
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses | Q28131633 | ||
The decline of androgen levels in elderly men and its clinical and therapeutic implications | Q28251483 | ||
Osteoporosis in older men: recent advances in pathophysiology and treatment. | Q34372545 | ||
Biochemical markers of bone turnover in men. | Q34454776 | ||
Heterogeneity of biological bone markers in idiopathic male osteoporosis. | Q51162653 | ||
Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients. | Q51351201 | ||
Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption | Q70483489 | ||
Sex steroids, biochemical markers, bone mineral density and histomorphometry in male osteoporosis patients | Q73316796 | ||
Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis | Q73399683 | ||
Effect of vitamin K and/or D on undercarboxylated and intact osteocalcin in osteoporotic patients with vertebral or hip fractures | Q73510595 | ||
Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy | Q74118878 | ||
Decreased estradiol levels and free androgen index and elevated sex hormone-binding globulin levels in male idiopathic osteoporosis | Q74452944 | ||
Cross-sectional evaluation of bone metabolism in men | Q74488846 | ||
Bone mineral density in men with genetic hemochromatosis and HFE gene mutation | Q81803540 | ||
Reduced levels of serum IGF-1 is related to the presence of osteoporotic fractures in male idiopathic osteoporosis | Q84625931 | ||
An overview of the metabolic functions of osteocalcin | Q86993895 | ||
The clinical epidemiology of male osteoporosis: a review of the recent literature | Q34461544 | ||
Endocrine regulation of male fertility by the skeleton | Q34642934 | ||
Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses | Q35080192 | ||
Gamma-carboxylation and fragmentation of osteocalcin in human serum defined by mass spectrometry | Q35692114 | ||
Testosterone regulates bone response to inflammation. | Q35910549 | ||
New insights into the biology of osteocalcin | Q36349628 | ||
Vitamin K-dependent carboxylation of osteocalcin: friend or foe? | Q36828712 | ||
A crosstalk between bone and gonads. | Q37975223 | ||
The mutual dependence between bone and gonads | Q37992601 | ||
Idiopathic osteoporosis in men. | Q38139875 | ||
Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups. | Q38188708 | ||
Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro | Q41491080 | ||
Total estradiol, rather than testosterone levels, predicts osteoporosis in aging men. | Q43176613 | ||
Bone turnover markers and sex hormones in men with idiopathic osteoporosis | Q43622940 | ||
Trabecular bone microstructure and local gene expression in iliac crest biopsies of men with idiopathic osteoporosis. | Q43989185 | ||
Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro | Q44768465 | ||
Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis | Q44933416 | ||
Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis | Q45100402 | ||
The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women | Q45265577 | ||
Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis | Q46659969 | ||
Growth hormone secretion and sensitivity in men with idiopathic osteoporosis | Q48910664 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | testosterone | Q27863114 |
osteocalcin | Q59250722 | ||
P304 | page(s) | 9892048 | |
P577 | publication date | 2017-08-02 | |
P1433 | published in | BioMed Research International | Q17509958 |
P1476 | title | Serum Osteocalcin and Testosterone Concentrations in Adult Males with or without Primary Osteoporosis: A Meta-Analysis | |
P478 | volume | 2017 |
Q92256490 | Analysis of the Relationship between the Levels of Androgens and Biochemical Bone Markers in Men Aged 60-75 Years |
Q91640426 | Associations of IDUA and PTCH1 with Bone Mineral Density, Bone Turnover Markers, and Fractures in Chinese Elderly Patients with Osteoporosis |
Q90080147 | The Endocrine Function of Osteocalcin Regulated by Bone Resorption: A Lesson from Reduced and Increased Bone Mass Diseases |
Search more.